Ontogeny of EGF receptors during postnatal development of mouse small intestine. 1987

N Gallo-Payet, and P Pothier, and J S Hugon

This study was aimed at characterizing epidermal growth factor (EGF) receptors during postnatal development of the maturing mouse small intestine at a time when this tissue is in the constant presence of high levels of intraluminal EGF. Binding studies with [125I]EGF on isolated epithelial cells demonstrate the continued presence of EGF receptors along the entire length of the small intestine with minimal binding at birth (3.67 +/- 0.30%/mg protein) and increasing steadily throughout postnatal life to reach adult values (10.39 +/- 0.90%/mg protein) by the 26th day, with maximum binding on the 21st day (13.4 +/- 2.2%/mg protein). This EGF binding pattern is similar for all three segments studied but was more pronounced for duodenum and jejunum, especially from day 14 on when binding capacity is more elevated in the proximal segments than in the ileum. Competition-inhibition curves of [125I]EGF by EGF reveal the presence of two classes of binding sites for which the number of sites and affinity constants are lower at birth than in adults. The continued presence of EGF receptors in mouse small intestine throughout the postnatal period thus provides support for the possible role of EGF as a modulator in the functional development of the maturing gastrointestinal (GI) tract.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

N Gallo-Payet, and P Pothier, and J S Hugon
August 1978, Developmental biology,
N Gallo-Payet, and P Pothier, and J S Hugon
January 1988, Gastroenterology,
N Gallo-Payet, and P Pothier, and J S Hugon
January 1982, Voprosy meditsinskoi khimii,
N Gallo-Payet, and P Pothier, and J S Hugon
May 1984, Developmental biology,
N Gallo-Payet, and P Pothier, and J S Hugon
January 1982, Virchows Archiv. B, Cell pathology including molecular pathology,
N Gallo-Payet, and P Pothier, and J S Hugon
December 2001, American journal of physiology. Gastrointestinal and liver physiology,
N Gallo-Payet, and P Pothier, and J S Hugon
October 2022, Andrologia,
N Gallo-Payet, and P Pothier, and J S Hugon
February 2017, Bioscience, biotechnology, and biochemistry,
N Gallo-Payet, and P Pothier, and J S Hugon
February 2004, Biochimie,
Copied contents to your clipboard!